Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Rachel Hendrix's research focuses on biomarkers associated with neurodegenerative conditions, particularly Alzheimer's disease. Her work investigates the timing of biomarker changes in relation to symptom onset and the predictive value of cerebrospinal fluid (CSF) biomarkers for cognitive impairment risk in elderly populations. Hendrix has also explored CSF plasminogen inhibitor 1 (PAI-1) levels in association with dementia symptoms in Alzheimer's disease patients. Her recent publications include studies on immune activation biomarkers in the context of Alzheimer's disease and cognitive decline, as well as research on hyperhemolysis in sickle cell disease and intranasal corticosteroid use in patients with hematologic conditions. Hendrix has a h-index of 7 and has published 16 total citations, with 237 total citations.
Metrics
- h-index: 7
- Publications: 16
- Citations: 250
Selected Publications
-
Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature (2025)
-
Intranasal Corticosteroid Use and Risk of Invasive Fungal Sinusitis in Acute Myeloid Leukemia, Myelodysplastic Syndrome and Post Transplant Patients (2024)
Collaboration Network
Top Collaborators
- Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF Plasminogen inhibitor 1(PAI‐1) levels are associated with dementia symptoms in Alzheimer disease
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF Plasminogen inhibitor 1(PAI‐1) levels are associated with dementia symptoms in Alzheimer disease
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
- CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
Similar Researchers
Based on overlapping research topics